ZOSTER-006およびZOSTER-022試験中の被験者の虚弱度を評価する研究

基本情報

NCT ID

NCT03563183

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

26,976

治験依頼者名

GlaxoSmithKline

概要

As part of the ZOSTER-006 and ZOSTER-022 pivotal trials of the HZ/su vaccine, all study participants completed quality of life (QoL) questionnaires. The only questionnaires encoded into the data base were those from participants who developed a suspected shingles episode during the study. The purpose of this study is to allow for the encoding and analysis of questionnaires for all subjects enrolled in ZOSTER-006 and ZOSTER-022. The aim is to assess the baseline frailty of subjects enrolled in these studies and to investigate whether this population is representative of the general population.

対象疾患

介入

依頼者（Sponsor）